Gosebruch Henry is a director or executive at Lakefront Biotherapeutics and is subject to EU Market Abuse Regulation disclosure requirements due to their senior position. Their role provides privileged access to material non-public information, requiring mandatory disclosure of securities transactions in company shares.
Rendement 1 an
+0.1%
Historique des transactions
2
Historique des transactions
2 transactions signal· 3 déclarées brutes1 transaction exclue des classements de signal. Un ou plusieurs dépôts pour cette personne semblent concerner une consolidation de compte, des transferts ou une restructuration de portefeuille. Affichés ci-dessous pour transparence mais exclus des calculs de performance et des flux de signaux.
Côté
🇧🇪
Reported purchaseGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
~€159K
@ €23.45
🇧🇪
Neutral — compensation/vestingGosebruch HenryEU MAR
LKFTOther
LAKEFRONT BIOTHERAPEUTICS
BE0003818359
Undisclosed
Not an insider buy/sell signal. This transaction is part of a compensation or vesting arrangement. Shares received through remuneration and subsequently sold for tax or liquidity purposes are classified as neutral and excluded from signal analysis.